₹ 15000
25% OFF ON ABOVE PRICE | USE CODE ML25 *
|
|
Non Invasive Prenatal Aneuploidies Screening (NIPT) Test |
|
|
Blood |
|
|
Doctor Prescription is must
|
|
|
|
|
₹ 15000 |
@3x.png)
Description
The Non-invasive Prenatal Testing (NIPT) is a prenatal screening test used to detect potential chromosomal abnormalities and other fetal health concerns. It provides expectant parents with early insights into their baby's genetic health. NIPT is a blood test recommended for all pregnant women, but especially those in certain categories with a higher risk of chromosomal abnormalities.
The NIPT Test is a sensitive screening test that primarily assesses the condition of Down syndrome (trisomy 21), Edwards syndrome (trisomy 18), and Patau syndrome (trisomy 13).
NIPT lab tests can also detect abnormalities in sex chromosomes and other genetic conditions. While it's a valuable tool, it's important to remember:
NIPT is a screening test: It indicates an increased risk of an abnormality, but it's not diagnostic. Further testing may be needed.
NIPT doesn't detect all abnormalities: It focuses on specific chromosomal conditions.
NIPT blood test reports can help in determining the sex of the fetus. Moreover, a non-invasive prenatal paternity test can be performed as early as the 7th week of pregnancy to determine the paternity of the fetus.
Unlike other invasive tests like Chorionic villus sampling (CVS), amniocentesis, and percutaneous umbilical blood sampling, a basic NIPT test poses no risk to the fetus.
Chromosomal abnormalities can happen during fetal development or egg/sperm formation due to errors in cell division (meiosis or mitosis). While maternal age is a risk factor, these abnormalities can occur in pregnancies regardless of age or health history.
NIPT test can scan several key abnormalities and help doctors and parents-to-be to prepare for and manage pregnancy more effectively.
While there are no outward signs that indicate chromosomal disorders, pregnancies that are at a higher risk conditions include,
Recommended Tests
FAQs
Description
The Non-invasive Prenatal Testing (NIPT) is a prenatal screening test used to detect potential chromosomal abnormalities and other fetal health concerns. It provides expectant parents with early insights into their baby's genetic health. NIPT is a blood test recommended for all pregnant women, but especially those in certain categories with a higher risk of chromosomal abnormalities.
The NIPT Test is a sensitive screening test that primarily assesses the condition of Down syndrome (trisomy 21), Edwards syndrome (trisomy 18), and Patau syndrome (trisomy 13).
NIPT lab tests can also detect abnormalities in sex chromosomes and other genetic conditions. While it's a valuable tool, it's important to remember:
NIPT is a screening test: It indicates an increased risk of an abnormality, but it's not diagnostic. Further testing may be needed.
NIPT doesn't detect all abnormalities: It focuses on specific chromosomal conditions.
NIPT blood test reports can help in determining the sex of the fetus. Moreover, a non-invasive prenatal paternity test can be performed as early as the 7th week of pregnancy to determine the paternity of the fetus.
Unlike other invasive tests like Chorionic villus sampling (CVS), amniocentesis, and percutaneous umbilical blood sampling, a basic NIPT test poses no risk to the fetus.
Chromosomal abnormalities can happen during fetal development or egg/sperm formation due to errors in cell division (meiosis or mitosis). While maternal age is a risk factor, these abnormalities can occur in pregnancies regardless of age or health history.
NIPT test can scan several key abnormalities and help doctors and parents-to-be to prepare for and manage pregnancy more effectively.
While there are no outward signs that indicate chromosomal disorders, pregnancies that are at a higher risk conditions include,
The Non-invasive Prenatal Testing (NIPT) is a prenatal screening test used to detect potential chromosomal abnormalities and other fetal health concerns. It provides expectant parents with early insights into their baby's genetic health.
NIPT is a screening test performed during pregnancy. A high-risk NIPT blood test result may necessitate further testing like amniocentesis or chorionic villus sampling (CVS) for confirmation.
The best time for the NIPT test is around the 10th week of pregnancy. At Max Lab, the NIPT test can be ordered at home as part of the first-trimester screening. However, the accuracy of the test may vary and NIPT test results may not always be reliable. Especially for women who,
Max Lab typically takes up to two weeks to deliver results after the collection of the NIPT test sample. The NIPT test should be performed under the supervision of a healthcare provider. From Max Lab, one can book a NIPT Test online and opt for home sample collection at a reasonable cost (the price of the NIPT blood test may slightly vary from city to city).
The NIPT test results are usually classified as low-risk or high-risk. A high-risk result requires further testing and consultation with a healthcare provider. Genetic counseling can also help understand the implications and make informed decisions
A NIPT test does not indicate a normal range, instead, the markers are classified as low-risk and high-risk.
Chromosomal disorders are the genetic makeup of an individual. While there is no cure for these conditions, ongoing treatment, healthcare strategies and supportive measures can make life easier for the affected. Besides early detection through NIPT blood tests during pregnancy, genetic counselling and emotional counselling can help parents-to-be prepare them.
While genetic abnormalities, such as those found in the NIPT test cannot be prevented entirely, certain measures and steps before and during pregnancy can reduce the risk. Some of these steps include,
.png)
7982100200
Test Name 
Sample Type 
Gender 
Age group 
Pre-test Instruction 
Price
To reach our help desk call 9213188888